Company / SG&A Expense
Schrödinger, Inc. SG&A Expense History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$95.4M
FY2025
5-year range
$27.0M / $99.7M
FY2021-FY2025
Trend
-4.3%
vs FY2024
Sector context
#134 of 158
Health Care
What the data says
Schrödinger, Inc.'s sg&a expense of $95M is lower than 85% of companies in the Health Care sector (FY2025). Improved from $99M to $95M over the past 2 years.
Based on SEC 10-K filings.
$95M in FY2025 with a 5-year CAGR of +28.7%.
Improved from $99M to $95M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +31.6%
- 5-Year CAGR
- +28.7%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 158This company $95.4M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +28.7%, indicating consistent growth.
- In FY2025, sg&a expense decreased 4.3% year-over-year.
- Ranks #134 out of 158 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $95.4M | -4.3% |
| FY2024 | $99.7M | +0.5% |
| FY2023 | $99.1M | +136.6% |
| FY2022 | $41.9M | +54.9% |
| FY2021 | $27.0M | +0.0% |
| FY2020 | $27.0M | +0.0% |
| FY2019 | $27.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026